- Home
- BKSY vs KROS Comparison
BKSY vs KROS Comparison
Compare BKSY & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKSY
- KROS
- Stock Information
- Founded
- BKSY 2013
- KROS 2015
- Country
- BKSY United States
- KROS United States
- Employees
- BKSY N/A
- KROS N/A
- Industry
- BKSY Radio And Television Broadcasting And Communications Equipment
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- BKSY Technology
- KROS Health Care
- Exchange
- BKSY Nasdaq
- KROS Nasdaq
- Market Cap
- BKSY 699.0M
- KROS 565.0M
- IPO Year
- BKSY N/A
- KROS 2020
- Fundamental
- Price
- BKSY $16.73
- KROS $16.98
- Analyst Decision
- BKSY Strong Buy
- KROS Buy
- Analyst Count
- BKSY 5
- KROS 14
- Target Price
- BKSY $29.00
- KROS $20.67
- AVG Volume (30 Days)
- BKSY 1.9M
- KROS 1.4M
- Earning Date
- BKSY 11-06-2025
- KROS 11-05-2025
- Dividend Yield
- BKSY N/A
- KROS N/A
- EPS Growth
- BKSY N/A
- KROS N/A
- EPS
- BKSY N/A
- KROS 1.57
- Revenue
- BKSY $101,731,000.00
- KROS $246,718,000.00
- Revenue This Year
- BKSY $14.63
- KROS $6,657.47
- Revenue Next Year
- BKSY $33.87
- KROS N/A
- P/E Ratio
- BKSY N/A
- KROS $10.82
- Revenue Growth
- BKSY N/A
- KROS 37798.31
- 52 Week Low
- BKSY $6.15
- KROS $9.12
- 52 Week High
- BKSY $33.20
- KROS $72.37
- Technical
- Relative Strength Index (RSI)
- BKSY 35.05
- KROS 70.27
- Support Level
- BKSY $15.20
- KROS $14.86
- Resistance Level
- BKSY $21.46
- KROS $15.30
- Average True Range (ATR)
- BKSY 1.85
- KROS 0.59
- MACD
- BKSY -0.85
- KROS 0.20
- Stochastic Oscillator
- BKSY 14.52
- KROS 92.03
About BKSY BlackSky Technology Inc.
BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.